Inventor · disambiguated record
John Mcneill Mcgill
Also filed as: MCGILL III JOHN M · MCGILL III JOHN MCNEILL · MCGILL JOHN M · MCGILL JOHN MCNEIL
16 granted patents·3 pending applications·169 citations·filing 1993–2015
92Inventor score
Top patents by PatentIndex Score
19 records- 0190US7939494B2Method for administering GLP-1 moleculesEMISPHERE TECH INC·Filed 2009·Granted May 10, 2011·16 cites·4 claims
- 0290US6177440B1Substituted tricyclicsLILLY CO ELI·Filed 1998·Granted Jan 23, 2001·60 cites·32 claims
- 0387US6713645B1Substituted tricyclicsLILLY CO ELI·Filed 2000·Granted Mar 30, 2004·21 cites·2 claims
- 0485US5629425AHaloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiopheneLILLY CO ELI·Filed 1994·Granted May 13, 1997·39 cites·5 claims
- 0578US7947841B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2008·Granted May 24, 2011·2 cites·15 claims
- 0678US7662771B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2004·Granted Feb 16, 2010·7 cites·10 claims
- 0768US8546581B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptideJUNGHEIM LOUIS NICKOLAUS·Filed 2011·Granted Oct 1, 2013·1 cites·13 claims
- 0867US8765796B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2013·Granted Jul 1, 2014·0 cites·12 claims
- 0961US5578713AOne step process for production of dirithromycinLILLY CO ELI·Filed 1993·Granted Nov 26, 1996·17 cites·22 claims
- 1059US2014005106A1Method for administering glp-1 moleculesEMISPHERE TECH INC·Filed 2013·Application pending·0 cites
- 1155US2007293423A1Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist PeptideLILLY CO ELI·Filed 2004·Application pending·0 cites
- 1251US2015202296A1Method for administering glp-1 moleculesEMISPHERE TECH INC·Filed 2015·Application pending·0 cites
- 1350US8492330B2Formulation comprising GLP-1KHAN MOHAMMED AMIN·Filed 2011·Granted Jul 23, 2013·0 cites·5 claims
- 1442US6008377ASynthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxy-benzo[B]thiophenesLILLY CO ELI·Filed 1996·Granted Dec 28, 1999·2 cites·32 claims
- 1539US5625065AStereoselective process for making endo-tropanamine and like compoundsLILLY CO ELI·Filed 1995·Granted Apr 29, 1997·2 cites·8 claims
- 1636US6472531B1Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxybenzo[b]thiophenesLILLY CO ELI·Filed 1995·Granted Oct 29, 2002·2 cites·5 claims
- 1732US6090949AProcesses for preparing benzothiophenesLILLY CO ELI·Filed 1998·Granted Jul 18, 2000·0 cites·11 claims
- 1828US6399778B1Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxybenzo[b]thiophenesLILLY CO ELI·Filed 1995·Granted Jun 4, 2002·0 cites·10 claims
- 1922US6025495ARegioselective alkylation process for preparing substituted benzo[b]thiophenesLILLY CO ELI·Filed 1998·Granted Feb 15, 2000·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →